Alyeska Investment Group’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Hold |
235,705
| – | – | ﹤0.01% | 534 |
|
|
2025
Q1 | $229K | Hold |
235,705
| – | – | ﹤0.01% | 481 |
|
|
2024
Q4 | $349K | Hold |
235,705
| – | – | ﹤0.01% | 528 |
|
|
2024
Q3 | $500K | Hold |
235,705
| – | – | ﹤0.01% | 486 |
|
|
2024
Q2 | $575K | Hold |
235,705
| – | – | ﹤0.01% | 461 |
|
|
2024
Q1 | $1.53M | Sell |
235,705
-200,000
| -46% | -$1.3M | 0.01% | 381 |
|
|
2023
Q4 | $1.68M | Buy |
435,705
+37,897
| +10% | +$146K | 0.01% | 358 |
|
|
2023
Q3 | $851K | Hold |
397,808
| – | – | 0.01% | 410 |
|
|
2023
Q2 | $1.21M | Hold |
397,808
| – | – | 0.01% | 412 |
|
|
2023
Q1 | $1.03M | Buy |
397,808
+191,607
| +93% | +$498K | 0.01% | 371 |
|
|
2022
Q4 | $423K | Hold |
206,201
| – | – | ﹤0.01% | 378 |
|
|
2022
Q3 | $930K | Hold |
206,201
| – | – | 0.01% | 338 |
|
|
2022
Q2 | $843K | Hold |
206,201
| – | – | 0.01% | 504 |
|
|
2022
Q1 | $907K | Hold |
206,201
| – | – | 0.01% | 527 |
|
|
2021
Q4 | $2.46M | Hold |
206,201
| – | – | 0.03% | 413 |
|
|
2021
Q3 | $3.54M | Hold |
206,201
| – | – | 0.04% | 394 |
|
|
2021
Q2 | $3.6M | Buy |
+206,201
| New | +$3.6M | 0.04% | 410 |
|